منابع مشابه
Tumor marker CA 15-3 in breast cancer patients.
OBJECTIVE The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast cancer with the presence of regional and distant metastases. PATIENTS AND METHODS The study was a retrospective-prospective study, and was conduct...
متن کاملGlypican-3 as a tumor marker for hepatocellular carcinoma
Article history: Received on: 13/03/2013 Revised on: 04/04/2013 Accepted on: 05/05/2013 Available online: 27/06/2013 Hepatocellular carcinoma(HCC) is one of the most frequent cancers in the world.The burden of HCC has been increasing in Egypt with a doubling in the incidence in the past ten years. The prognosis of most patients is unsatisfactory due to rapid clinical deterioration after the ini...
متن کاملPrevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
Background: Ovarian carcinoma is one of the leading causes of cancer-related death among females. K-ras codon 12 mutations are commonly occurring mutations in different types of cancers and leads to resistance against anti-EGFR therapeutics. Hence, determination of mutations in k-ras gene is crucial for predicting response to anti-EGFR therapies. This study aimed to evaluate the prevalence of k...
متن کاملEvaluation of a newly developed quantitative determination kit for tumor marker CA15‐3 with chemiluminescent assay
BACKGROUND Tumor marker carbohydrate antigen 15-3 (CA15-3) is used as a biomarker to aid to diagnose and monitor the prognosis of breast cancer patients. A new quantitative determination kit for CA15-3 with chemiluminescent assay was developed by Xiamen InnoDx Biotech Co., Ltd, China. Therefore, we conducted the report to evaluate the performance of the kit. METHODS According to the "Guiding ...
متن کاملTumor Marker Monitoring
Reduce cost of care An obvious goal is to enhance patient care. We have to remember that tumor markers are not treatments and that the relevance of tumor markers for particular cancers are only as good as the treatments allow them to be. The other speakers have made that observation also. So how can tumor markers enhance patient care? Hopefull~ they can extend survival time and improve the qual...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kagaku To Seibutsu
سال: 1988
ISSN: 0453-073X,1883-6852
DOI: 10.1271/kagakutoseibutsu1962.26.599